A new collaboration aims to accelerate genomic medicine by improving manufacturing, scalability, and efficiency in cell and gene therapies, focusing on key bottlenecks in development.
Clinical Trials Arena on MSN
Roche to launch global study of Elevidys following EU rejection
Roche will be launching the Phase III trial to gain approval of Elevidys in Europe and other countries globally.
GlobalData on MSN
The innovators working to make in vivo cell therapy a reality
As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.
Cytiva, a Danaher company and a leader in the life sciences industry, together with the San Raffaele Telethon Institute for Gene Therapy (SRTIGET), launched a new collaboration to advance next ...
Get ASPIRE-BioNEST News on Telangana Today, ASPIRE-BioNEST latest news, ASPIRE-BioNEST news, | Telangana Today ...
RT-MALS can provide instantaneous measurements of adenovirus particle size and titer during downstream and fill–finish ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
As cell and gene therapy developers face rising pressure to produce therapies faster and at lower cost, the industry is ...
Many promising life science innovations struggle to achieve widespread adoption – but why? What differentiates technologies ...
Despite persistent cost concerns, continued innovation is reinforcing the chromatography resin market’s long-term growth.
The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results